日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting metabolic vulnerabilities: REV-ERB agonist SR9009 potentiates sorafenib efficacy in liver cancer.

靶向代谢脆弱性:REV-ERB 激动剂 SR9009 可增强索拉非尼在肝癌中的疗效。

Sabbioni Silvia, Guerriero Paola, Shankaraiah Ram C, Masatti Laura, Michilli Angelo, Bassi Cristian, D'Abundo Lucilla, Moshiri Farzaneh, De Siena Bruno, Simoni Edi, Astolfi Laura, Gramantieri Laura, Roncarati Roberta, Elamin Bahaeldin K, Bonora Massimo, Pinton Paolo, Croce Carlo M, Negrini Massimo, Callegari Elisa

Circulating miR-22 Early Predicts TACE Non-Response and Targets WEE1 in Hepatocellular Carcinoma

循环 miR-22 可早期预测 TACE 无反应,并在肝细胞癌中靶向 WEE1

Gramantieri, Laura; Vianello, Clara; Leoni, Ilaria; Galvani, Giuseppe; Monti, Elisa; Bella, Marco; Marisi, Giorgia; Salamon, Irene; Ferracin, Manuela; Ravegnini, Gloria; Giovannini, Catia; Stefanelli, Claudio; Lazzari, Maria Laura; Piscaglia, Fabio; Coada, Camelia A; Bassi, Cristian; Negrini, Massimo; Casadei-Gardini, Andrea; Foschi, Giuseppe Francesco; Trerè, Davide; Fornari, Francesca

Corrigendum to < 'Characterization of small nucleolar RNA retaining transcripts in human normal and cancer cells'> <[Non-coding RNA Research vol. 13 (2025) 153-161]>

更正:《人类正常细胞和癌细胞中小核仁RNA保留转录本的特征分析》<[非编码RNA研究,第13卷(2025年),153-161页]>

Rambaldelli, G; Asghar, S; Venturi, G; Zacchini, F; Serra, M; Giovannini, C; Gramantieri, L; Bernini, M; Inga, A; Dassi, E; Montanaro, L

TG221: An Experimental Model for Liver Cancer Prevention and Treatment Approaches

TG221:肝癌预防和治疗方法的实验模型

Callegari, Elisa; Michilli, Angelo; Moshiri, Farzaneh; De Siena, Bruno; Gramantieri, Laura; Negrini, Massimo; Sabbioni, Silvia

Early CTLA4 increase in CD45+ blood cells: an emerging biomarker of atezolizumab-bevacizumab resistance and worse survival in advanced hepatocarcinoma

CD45+血细胞中CTLA4早期升高:晚期肝癌中阿特珠单抗-贝伐珠单抗耐药和生存期缩短的新兴生物标志物

Gramantieri, L; Montagner, A; Arleo, A; Suzzi, F; Bassi, C; Tovoli, F; Bruccoleri, M; Alimenti, E; Fornari, F; Iavarone, M; Negrini, M; Piscaglia, F; Giovannini, C

MiR-22/GLUT1 Axis Induces Metabolic Reprogramming and Sorafenib Resistance in Hepatocellular Carcinoma

miR-22/GLUT1轴诱导肝细胞癌代谢重编程和索拉非尼耐药

Leoni, Ilaria; Galvani, Giuseppe; Monti, Elisa; Vianello, Clara; Valenti, Francesca; Pincigher, Luca; Grolla, Ambra A; Moro, Marianna; Coada, Camelia A; Perrone, Alessandro; Righi, Valeria; Marinelli, Sara; Ravegnini, Gloria; Giovannini, Catia; Baldassarre, Maurizio; Pariali, Milena; Ravaioli, Matteo; Cescon, Matteo; Vasuri, Francesco; Domenicali, Marco; Negrini, Massimo; Piscaglia, Fabio; Fato, Romana; Stefanelli, Claudio; Gramantieri, Laura; Bergamini, Christian; Fornari, Francesca

Characterization of small nucleolar RNA retaining transcripts in human normal and cancer cells

对人类正常细胞和癌细胞中保留小核仁RNA的转录本进行表征

Rambaldelli, Guglielmo; Asghar, Sidra; Venturi, Giulia; Zacchini, Federico; Serra, Margherita; Giovannini, Catia; Gramantieri, Laura; Bernini, Marco; Inga, Alberto; Dassi, Erik; Montanaro, Lorenzo

Multifaceted Aspects of Dysfunctional Myelopoiesis in Cancer and Therapeutic Perspectives with Focus on HCC

癌症中骨髓造血功能障碍的多方面及治疗前景——以肝细胞癌为例

Arleo, Andrea; Montagner, Annapaola; Giovannini, Catia; Suzzi, Fabrizia; Piscaglia, Fabio; Gramantieri, Laura

MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma

miR-494通过靶向G6pc诱导代谢改变,并调节肝细胞癌对索拉非尼的反应。

Christian Bergamini # ,Ilaria Leoni # ,Nicola Rizzardi # ,Mattia Melli ,Giuseppe Galvani ,Camelia Alexandra Coada ,Catia Giovannini ,Elisa Monti ,Irene Liparulo ,Francesca Valenti ,Manuela Ferracin ,Matteo Ravaioli ,Matteo Cescon ,Francesco Vasuri ,Fabio Piscaglia ,Massimo Negrini ,Claudio Stefanelli ,Romana Fato ,Laura Gramantieri ,Francesca Fornari

Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area

低暴露区肝细胞癌中的黄曲霉毒素B1 DNA加合物

Gramantieri, Laura; Gnudi, Federica; Vasuri, Francesco; Mandrioli, Daniele; Fornari, Francesca; Tovoli, Francesco; Suzzi, Fabrizia; Vornoli, Andrea; D'Errico, Antonia; Piscaglia, Fabio; Giovannini, Catia